Business Wire

Thread Group Opens Testing to Members as ARM, NXP and Silicon Labs Bring First Conforming Stacks to Market

Del

In its effort to drive adoption of the Thread networking protocol in the connected home and beyond, the Thread Group today announced the release of its initial hardware reference test bed and test harness, as well as the opening of its test lab to members. Further, the Thread Group also announced that the test bed participants ARM, NXP and Silicon Labs have released the first conforming stacks that have successfully passed testing based on the Thread 1.1 technical specification. This announcement opens the door for member companies to utilize the Thread test resources - test bed, test harness and UL’s lab - to test products for conformance based on the 1.1 specification.

“The arrival of this milestone generates a new wave of momentum for Thread. We’re very excited to see the first Thread 1.1-conforming stacks come to market, and for our member companies to move their Thread-enabled products towards commercial availability,” said Grant Erickson, president of the Thread Group. “As an organization, we’re addressing a profound gap in the way we connect things where people live and work -- an easy-to-use, IP-based, resilient, low-power, and secure way to connect and control products -- and we’re very pleased that our memberships’ vision, collaboration, and hard work are coming to fruition.”

Members of the Thread Group can access a number of advanced tools and resources to support their product development lifecycle. The Thread Group provides a hardware test bed, which includes multiple silicon and stack implementations. It also collaborated with Granite River Labs to develop a test harness which runs automated test scripts on the test bed - confirming proper functionality, while enabling the highest degree of speed and repeatability in the testing process. The test harness features an automated DUT (device under test) and API (programming interface) that enables members to integrate the Thread test harness into their internal automated testing environment and run constant regression testing.

The Thread Group has a number of leading silicon providers in its membership, and with the addition of the test resources, the group expects to see additional conforming stacks come to market in the coming months. The Thread Group is now working with UL Labs to perform interoperability testing with the conformant stacks from ARM, NXP, and Silicon Labs. Upon the successful completion of interoperability tests, Thread will designate these stacks as “Thread certified.” The Thread Group expects to meet this milestone in late 2016.

“Silicon Labs is committed to Thread as one of the founding member companies to build a better solution to connect products within the home, and we have worked alongside many companies to bring that technology to market,” said Skip Ashton, Vice President of Software at Silicon Labs. “Our customers are excited about the potential of Thread since we first announced the venture, and we’re very pleased to begin shipping the conforming stacks to our customers in so they can begin building products.”

“As a founding and active member of Thread, NXP is committed to establishing and evolving the protocol and its specs. We’re pleased to be one of the first to market with a compliant end-to-end solution that meets the needs of the entire Thread network,” said Emmanuel Sambuis, Vice President of Microcontrollers at NXP Semiconductors. “The powerful combination of our Thread conformant stack optimized for our broad portfolio of products, which include Kinetis MCUs and i.MX Application Processors, will significantly help drive new secure and IP-based solutions for the smart home.”

“ARM, a founding member of the Thread Group, has prioritized Thread as a strategic networking protocol for the Internet of Things (IoT),” said Michael Horne, deputy general manager, IoT Business, ARM. “The protocol is supported by ARM® mbed™ OS 5.2, a fully conformant software stack with automated testing that ensures high-quality implementations. Simultaneous availability from multiple suppliers of Thread stacks optimized for ARM-based silicon will accelerate IoT device development and deployment at scale.”

About Thread

Designed for devices and things in the places where people live and work, Thread is an IPv6 networking protocol built on open standards for low-power 802.15.4 mesh networks that can easily and securely connect hundreds of devices to each other and directly to the cloud. The non-profit Thread Group is focused on making Thread the foundation for the Internet of Things in the home and beyond, educating product developers, builders and consumers on the unique features and benefits of Thread and ensuring a positive experience through rigorous, meaningful product certification. Thread is backed by industry-leading companies including ARM, Big Ass Solutions, Nest Labs, NXP, OSRAM, Qualcomm, Samsung Electronics, Schneider Electric, Silicon Labs, Somfy, Tyco and Yale Security. Since opening its membership in October 2014, Thread has grown quickly to include a diverse membership. For more information, please visit http://www.threadgroup.org.

Contact information

for Thread Group
Gabriella Asmus, 415-348-2721
thread@finnpartners.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

ViiV Healthcare Shares Data from Landmark 2-Drug Regimen Trials At AIDS 201818.7.2018 17:21Pressemelding

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, will be presenting over 20 abstracts, including data from the landmark GEMINI 1 & 2 clinical trials, at the 22nd International AIDS Conference (AIDS 2018), 23-27 July 2018, in Amsterdam, The Netherlands. The data being presented this year has a strong focus on novel exploratory therapeutic options and innovative treatment strategies, as well as improving awareness and understanding of key issues that continue to affect the HIV community. John C Pottage, Jr, MD, Chief Scientific and Medical Officer, ViiV Healthcare, commented, “As we see advancements in the treatment options available to people living with HIV, our research efforts over the past few years have been focused on moving beyond viral load and addressing some of the unresolved issues that people living with HIV face, such as the potential long-term risks and toxicities that can be associated with li

Xilam: H1 2018 Revenue: +50%18.7.2018 16:00Pressemelding

Regulatory News: The Xilam Group (Paris:XIL) posted consolidated H1 2018 revenue of EUR 13,866 thousand, an increase of 50%. This increase represents an excellent performance, as it follows on the heels of growth of 54% in H1 2017. Revenue for the first part of this financial year breaks down as follows. In thousands of euros 30.06.2018 (1) 30.06.2017 Change New productions 8,465 4,571 +85% Catalogue 5,385 4,652 +16% Other 16 16 +0% Revenue and subsidies 13,866 9,239 +50% (1) Unaudited data. Remarkable success for new releases +85% Excellent H1 growth was driven by the two main businesses, New Productions and Catalogue. In New Productions, H1 deliveries generated record revenue of EUR 8,465 thousand, an 85% increase compared with H1 2017, and confirmed Xilam’s position as a major European animation company. Catalogue revenue was up 16% compared with H1 2017, thanks again to traditional TV channels and digital platforms, in both France and abroad. A fast-paced delivery schedule Thanks t

Department for International Trade: Life Sciences at the Heart of UK Economy18.7.2018 12:38Pressemelding

The Government will today (Wednesday 18 July) host the second in a series of roundtables with stakeholders from key life science businesses, demonstrating the importance of the sector to the UK economy. The Chancellor, International Trade Secretary, Business Secretary and Health and Social Care Secretary will be amongst those that meet with senior representatives from leading UK and international life sciences companies as the UK positions itself as the global home of health innovation, welcoming overseas investment and seeking to boost exports in the process. Discussions at the roundtable will focus on how the future of the Life Sciences sector will be supported by the delivery of our modern Industrial Strategy, ensuring that the UK is ‘open for business’ with a positive business environment, our ambitions for a comprehensive agreement with the EU on our future relationship and the development and implementation of our independent trade policy. To date, the government has engaged sign

Universal Laser Systems Expands Its Materials Database with 3M, Victrex and Dexmet Materials18.7.2018 12:05Pressemelding

Universal Laser Systems (ULS) announces the addition of 3M™, Victrex® and Dexmet materials to its materials database, the most extensive repository of laser material processing parameters for materials in the range of 10 watts to 500 watts. The 3M, Victrex and Dexmet materials new to the ULS materials database were specifically added for laser processing with the ULTRA and XLS platforms, suited for high accuracy and precision laser cutting, laser ablation and laser surface modification. The materials include: 3M™ Extreme Sealing Tape 4412N 3M™ Thermally Conductive Silicone Interface Pad 5516 Victrex® APTIV® PEEK Film Dexmet PolyGrid® 8PTFE10-125ST Expanded PTFE Dexmet MicroGrid® AL 25 Expanded Aluminum Laser processing notes, describing the results of the laser-material interaction for these materials, are also available in the Materials Library on the ULS website to help potential customers explore the advantages of deploying laser technology within their manufacturing, research and d

Sterigenics Expands European Capacity With New State-of-the-Art Gamma Sterilization Facility in the UK18.7.2018 12:00Pressemelding

Sterigenics, a Sotera Health company and leading global provider of mission-critical sterilization solutions and expert advisory services, announced today it is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK. The facility will significantly expand Sterigenics’ footprint in Europe to help meet the growing sterilization needs of its customers and support the company’s mission of Safeguarding Global HealthTM. Scheduled for completion in the fourth quarter, 2018, the facility will include the installation of a state-of-the-art Nordion JS10000 gamma irradiator with a research loop. The new 60,000-square-foot facility will add gamma sterilization capabilities in the UK to complement Sterigenics’ existing ethylene oxide (EtO) facility based in Somercotes/Derbyshire. “Sterigenics is committed to being the world’s leading provider of sterilization services and partnering with our customers to eliminate threats to human health,” said Philip Macnabb, President of Ste

Smiths Detection Technology Chosen for Standard 3 Upgrade at Helsinki Airport18.7.2018 09:05Pressemelding

Smiths Detection has been selected by Finnish airport operator, Finavia Corporation, to support the transition to Standard 3 at Helsinki Airport with approved hold baggage screening systems. Included in the contract are eight high-speed, HI-SCAN 10080 XCT scanners, which combine high resolution X-ray technology, computed tomography (CT) and advanced detection algorithms to increase both security and operational efficiency significantly. Security, speed and efficiency are critical to the extensive development programme underway at the airport, which will allow the airport to serve 30 million passengers annually and increase baggage handling capacity by 50%. “Any financial investment in upgrading security equipment has to be balanced against operational improvement, particularly when part of a major expansion. Airports need assurance that efficiencies will be gained and systems can be further updated as necessary to detect evolving explosive threats and handle ever higher volumes,” comme